China focus: Research findings, co-enzyme q10 supplements, regulatory roadblock, expansion into China and more

By Hui Ling Dang

- Last updated on GMT

Research findings, co-enzyme q10 supplements, regulatory roadblock, expansion into China and more

Related tags China

This round-up looks at the latest research findings, soaring demand for co-enzyme Q10 supplements in China, regulatory roadblock for a Chinese NMN supplier, a Korean supplement firm’s expansion into China, and more.

Co-enzyme Q10 hot in demand in China amid sharp jump in COVID-19 cases

Chinese media Yicai reported on January 13 that some brands were sold out of co-enzyme supplements and more investors of supplement firms were enquiring about co-enzyme.

It was also reported that online search for co-enzyme q10 supplements has increased on e-commerce platforms such as Tmall and Taobao, with the latter seeing more than 2,500% increase in search volume.

A reason for the surge in demand is due to the belief that co-enzyme Q10 could prevent myocarditis (inflammation of the heart muscle) in individuals who have recovered from COVID-19.

‘Not so dire?’ China NMN supplier hopeful of US opportunities despite regulatory roadblock

A form of vitamin B3 and commonly marketed as an anti-ageing ingredient, nicotinamide mononucleotide (NMN) was previously approved as a New Dietary Ingredient (NDI) by the US FDA. However, the regulator changed its position last November.

Effepharm, a Shanghai-based NMN ingredient supplier, submitted an NDI notification to the US FDA on 5 December last year and was told to furnish more documentation. Other companies that received NDI approval for their NMN ingredients or products also had their approvals retracted. 

As the US FDA has yet to make an official announcement on its final stance on NMN, Effepharm believes that there is “still hope” for NMN’s use in dietary supplements.

Black tea may have preventive effect on ovarian cancer – new Chinese meta-analysis

Black tea may lower the risk of ovarian cancer, according to Chinese researchers, although no significant correlation with endometrial cancer and cervical cancer was found.

Findings from a meta-analysis based on 19 cohort studies showed that non-herbal tea had significant preventive impact on ovarian cancer (pooled relative risk of 0.67), especially for black tea (pooled relative risk of 0.64).

 

E-commerce expansion: South Korean supplement firm Yuhan Care sets sights on China, South East Asia

South Korean health supplement firm Yuhan Care, a pioneer in the domestic women’s health sector, is on a mission to expand its presence in China and South East Asia.

Yuhan Care is a part of Yuhan Corp – a firm with roots in the pharmaceutical industry. More recently, it has branched into consumer health with presence in the supplements, food, and cosmetics space.

One of the firm’s specialities is in women’s health, where it owns patented probiotic strains Lactobacillus rhamnosus ​GR-1 and Lactobacillus reuteri ​RC-14 that claim to benefit the reproductive system.

Selenium supplementation may lower insulin resistance in cardio-metabolic disease patients: Chinese meta-analysis 

Selenium supplementation may be effective in reducing insulin resistance in those with cardio-metabolic diseases (CMDs), according to a systematic review and meta-analysis by researchers in China.

The analysis looked at 10 RCTs involving 526 participants, with insulin levels, insulin resistance, fasting plasma glucose and glycosylated haemoglobin A1C (HbA1c) as the primary outcome markers, while lipid markers are the secondary outcome markers.

In a sub-group analysis, the review found that selenium supplementation actually increased HDL cholesterol levels more significantly in cardiovascular disease patients, followed by diabetes patients.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Full Vegan Protein Ingredients Solution

Full Vegan Protein Ingredients Solution

Content provided by Ingredients4u AG | 24-Jul-2023 | Product Brochure

Plant-based products have always been a hot topic in the market, the plant-based food market was valued at $29.4 billion in 2020.

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast